Association between contrast enhancement on contrast-enhanced CT and lenvatinib effectiveness in hepatocellular carcinoma

The aim of the present study was to investigate whether the degree of contrast enhancement on contrast-enhanced (CE)-CT can predict the prognosis of patients with hepatocellular carcinoma (HCC) treated with lenvatinib (LEN). A total of 67 consecutive patients with LEN-treated HCC were retrospectivel...

Descripción completa

Detalles Bibliográficos
Autores principales: Okamura, Shusuke, Shimose, Shigeo, Niizeki, Takashi, Kamachi, Naoki, Noda, Yu, Shirono, Tomotake, Iwamoto, Hideki, Nakano, Masahito, Kuromatsu, Ryoko, Koga, Hironori, Torimura, Takuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647186/
https://www.ncbi.nlm.nih.gov/pubmed/34881028
http://dx.doi.org/10.3892/mco.2021.2442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647186/
https://www.ncbi.nlm.nih.gov/pubmed/34881028
http://dx.doi.org/10.3892/mco.2021.2442

Ejemplares similares